From Left to Right: Tricia Merriam, Revenue Cycle Manager, Infusion, Cooper Cancer Institute and Meghan Vizzard, 12, Sixth Grade Student at Hartford School in Mt. Laurel.

When her nineteen-year-old cousin Katie was diagnosed with ovarian cancer in November 2011, Meghan Vizzard of Mount Laurel wanted to make her a gift that would provide some comfort to her once she began her treatment. It was a handmade fleece blanket that Katie used every day during her nine week course of chemotherapy. Read the full story

Cooper Cancer Institute was recently named a “Center of Excellence” in accelerated partial breast irradiation (APBI) for its use of the SAVI^® applicator, an advanced therapy for breast cancer as part of breast conservation therapy. Read the full story

The Avon Breast Health Outreach Program has awarded a $35,000 one-year grant to Cooper Cancer Institute to increase awareness of the life-saving benefits of early detection of breast cancer. It is the fourth year that the program has received funding from the Avon Foundation for Women to support its work on this important health issue and in recognition of the program’s excellence. Read the full story

On Saturday, June, 4, 2011, more than 750 cancer survivors, family, friends and supporters came together to celebrate life at this year’s 8th Annual Survivors Day, hosted by Cooper Cancer Institute, Voorhees, N.J.

The day featured remarks from Dr. Generosa Grana, MD, Director of Cooper Cancer Institute and Kim Fisher, a cancer survivor and violinist with The Philadelphia Orchestra. Guests enjoyed chair massages, health screenings and wellness information, a therapeutic craft activity, children’s therapeutic play station, several games of bingo, a fancy hat contest and raffle drawings for the survivors.

Thanks to everyone who helped make the event a success!

Click on any of the photos below to view larger.

Cooper Cancer Institute will receive the Clinical Trials Participation Award (CTPA) from the Conquer Cancer Foundation of the American Society of Clinical Oncology, formerly known as The ASCO Cancer Foundation. The award recognizes Cooper for its work in improving cancer care through high-quality clinical trials programs. It will be presented to Cooper at ASCO’s 47th Annual Meeting in Chicago, June 3-7, 2011.

“At Cooper Cancer Institute, our number one goal is to be innovative, compassionate and focused on excellence in order to help improve and extend the lives of patients living with cancer,” explains Robert A. Somer, MD, the Director of the Clinical Trials Program, Division of Hematology/Medical Oncology at Cooper. “We are honored to be recognized as a leader in clinical research.”

Read the full story